DE602005006397D1 - Nukleosidanaloga mit antiviraler wirkung - Google Patents

Nukleosidanaloga mit antiviraler wirkung

Info

Publication number
DE602005006397D1
DE602005006397D1 DE602005006397T DE602005006397T DE602005006397D1 DE 602005006397 D1 DE602005006397 D1 DE 602005006397D1 DE 602005006397 T DE602005006397 T DE 602005006397T DE 602005006397 T DE602005006397 T DE 602005006397T DE 602005006397 D1 DE602005006397 D1 DE 602005006397D1
Authority
DE
Germany
Prior art keywords
antiviral effect
nucleoside analogue
preparation
nucleoside
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005006397T
Other languages
English (en)
Inventor
Ugo Chiacchio
Antonino Corsaro
Daniela Iannazzo
Beatrice Macchi
Antonio Mastino
Anna Piperno
Antonio Rescifina
Giovanni Romeo
Roberto Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNI DEGLI STUDI DI MESSINA
Universita degli Studi di Catania
Original Assignee
UNI DEGLI STUDI DI MESSINA
Universita degli Studi di Catania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNI DEGLI STUDI DI MESSINA, Universita degli Studi di Catania filed Critical UNI DEGLI STUDI DI MESSINA
Publication of DE602005006397D1 publication Critical patent/DE602005006397D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005006397T 2004-02-26 2005-02-25 Nukleosidanaloga mit antiviraler wirkung Active DE602005006397D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000099A ITRM20040099A1 (it) 2004-02-26 2004-02-26 Analoghi nucleosidici ad attivita' antivirale.
PCT/EP2005/050818 WO2005082896A1 (en) 2004-02-26 2005-02-25 Nucleoside analogues with antiviral activity

Publications (1)

Publication Number Publication Date
DE602005006397D1 true DE602005006397D1 (de) 2008-06-12

Family

ID=34897817

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005006397T Active DE602005006397D1 (de) 2004-02-26 2005-02-25 Nukleosidanaloga mit antiviraler wirkung

Country Status (5)

Country Link
EP (1) EP1727814B1 (de)
AT (1) ATE393768T1 (de)
DE (1) DE602005006397D1 (de)
IT (1) ITRM20040099A1 (de)
WO (1) WO2005082896A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114920733B (zh) * 2022-05-23 2023-09-29 河南师范大学 一种环加成合成手性异噁唑环及碳环核苷类似物的方法

Also Published As

Publication number Publication date
EP1727814A1 (de) 2006-12-06
WO2005082896A1 (en) 2005-09-09
EP1727814B1 (de) 2008-04-30
ATE393768T1 (de) 2008-05-15
ITRM20040099A1 (it) 2004-05-26

Similar Documents

Publication Publication Date Title
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
EA200802203A1 (ru) Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов
HK1093746A1 (en) Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
DK2114925T3 (da) Azetidin-analoger af nucleosidase- og phosphorylase-inhibitorer
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
MY136229A (en) Antiviral nucleoside derivatives
NO20064584L (no) Tetrahydropyridoindolderivater
SV2005001920A (es) " compuestos nucleosidos para el tratamiento de infecciones virales "
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
MX2022016405A (es) Análogos de nucleósido de 1¿-ciano y usos de estos.
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
TW200510343A (en) Substituted dihydroquinazolines
CL2004000270A1 (es) Compuestos derivados de pirazol, sus sales de adicion acidas,trastornos de vih y virus geneticamente relacionados. hidratos, solvatos; composiciones farmaceuticas; y su uso en el tramiento de trastornos del vih y virus geneticamente relacionados.
CY1113482T1 (el) Αναστολεις υποδοχεα σιγμα
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
TW200716616A (en) Modulators of CCR-5 activity
NO20065791L (no) Asyklovir-formuleringer
ATE548043T1 (de) Polymorphe von 3-o-(3',3'- dimethylsuccinyl)betulinsäure-di-n-methyl-d- glucamin
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
DE602005006397D1 (de) Nukleosidanaloga mit antiviraler wirkung
WO2004052905A3 (en) Antiviral nucleoside derivatives

Legal Events

Date Code Title Description
8332 No legal effect for de